Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo

Peng Wang, Corey M. Munger, Avadhut D. Joshi, Samuel Jay Pirruccello, Shantaram S Joshi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The Her2/neu oncogene encodes a transmembrane protein with homology to the epidermal growth factor receptor. Overexpression of this gene contributes to the aggressiveness of breast cancer and poor prognosis. Therefore, Her2/neu is an ideal target molecule for generating effective cytotoxic T lymphocytes (CTLs) against breast cancers. This study reports on the generation of Her2/neu-specific CTL from umbilical cord blood mononuclear cells (UCBC) using dendritic cells primed with Her2/neu-derived peptide (KIFGSLAFL, E75) for immunostimulation. The CTLs showed specific cytotoxicity to Her2/neu high expressing MDA-453 but not toward Her2/neu low expressing MDA-231 human breast cancer cells. Similarly generated CTLs stimulated with irrelevant peptide pulsed dendritic cells did not show significant cytotoxicity towards breast cancer targets. The phenotypes of cells in culture showed high percentage of CD3+, CD4+ and CD8+T cells as determined by flow cytometry. However, the antibody mediated blocking assay demonstrated that only HLA-Class I restricted CD8+ cells are involved in the cytotoxicity. Furthermore, in vivo studies showed that treatment of SCID mice bearing MDA-453 tumor with Her2/neu-specific CTLs resulted in significant inhibition of tumor growth compared to untreated tumor bearing control mice. These results demonstrate that human umbilical cord blood mononuclear cells are a good source for generating Her2/neu-specific CTLs against human breast cancer both in vitro and in vivo.

Original languageEnglish (US)
Pages (from-to)15-23
Number of pages9
JournalBreast Cancer Research and Treatment
Volume83
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Cytotoxic T-Lymphocytes
Fetal Blood
Breast Neoplasms
Dendritic Cells
Blood Cells
Neoplasms
Peptides
Blocking Antibodies
SCID Mice
Oncogenes
Epidermal Growth Factor Receptor
In Vitro Techniques
Immunization
Flow Cytometry
Cell Culture Techniques
T-Lymphocytes
Phenotype
Growth
Genes
Proteins

Keywords

  • Breast cancer
  • Cord blood
  • Cytotoxic T lymphocytes (CTLs)
  • Dendritic cells (DCs)
  • Her2/neu

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo. / Wang, Peng; Munger, Corey M.; Joshi, Avadhut D.; Pirruccello, Samuel Jay; Joshi, Shantaram S.

In: Breast Cancer Research and Treatment, Vol. 83, No. 1, 01.01.2004, p. 15-23.

Research output: Contribution to journalArticle

@article{f3a8f3a229994769a678b1dc01d8b37f,
title = "Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo",
abstract = "The Her2/neu oncogene encodes a transmembrane protein with homology to the epidermal growth factor receptor. Overexpression of this gene contributes to the aggressiveness of breast cancer and poor prognosis. Therefore, Her2/neu is an ideal target molecule for generating effective cytotoxic T lymphocytes (CTLs) against breast cancers. This study reports on the generation of Her2/neu-specific CTL from umbilical cord blood mononuclear cells (UCBC) using dendritic cells primed with Her2/neu-derived peptide (KIFGSLAFL, E75) for immunostimulation. The CTLs showed specific cytotoxicity to Her2/neu high expressing MDA-453 but not toward Her2/neu low expressing MDA-231 human breast cancer cells. Similarly generated CTLs stimulated with irrelevant peptide pulsed dendritic cells did not show significant cytotoxicity towards breast cancer targets. The phenotypes of cells in culture showed high percentage of CD3+, CD4+ and CD8+T cells as determined by flow cytometry. However, the antibody mediated blocking assay demonstrated that only HLA-Class I restricted CD8+ cells are involved in the cytotoxicity. Furthermore, in vivo studies showed that treatment of SCID mice bearing MDA-453 tumor with Her2/neu-specific CTLs resulted in significant inhibition of tumor growth compared to untreated tumor bearing control mice. These results demonstrate that human umbilical cord blood mononuclear cells are a good source for generating Her2/neu-specific CTLs against human breast cancer both in vitro and in vivo.",
keywords = "Breast cancer, Cord blood, Cytotoxic T lymphocytes (CTLs), Dendritic cells (DCs), Her2/neu",
author = "Peng Wang and Munger, {Corey M.} and Joshi, {Avadhut D.} and Pirruccello, {Samuel Jay} and Joshi, {Shantaram S}",
year = "2004",
month = "1",
day = "1",
doi = "10.1023/B:BREA.0000010688.55353.a8",
language = "English (US)",
volume = "83",
pages = "15--23",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo

AU - Wang, Peng

AU - Munger, Corey M.

AU - Joshi, Avadhut D.

AU - Pirruccello, Samuel Jay

AU - Joshi, Shantaram S

PY - 2004/1/1

Y1 - 2004/1/1

N2 - The Her2/neu oncogene encodes a transmembrane protein with homology to the epidermal growth factor receptor. Overexpression of this gene contributes to the aggressiveness of breast cancer and poor prognosis. Therefore, Her2/neu is an ideal target molecule for generating effective cytotoxic T lymphocytes (CTLs) against breast cancers. This study reports on the generation of Her2/neu-specific CTL from umbilical cord blood mononuclear cells (UCBC) using dendritic cells primed with Her2/neu-derived peptide (KIFGSLAFL, E75) for immunostimulation. The CTLs showed specific cytotoxicity to Her2/neu high expressing MDA-453 but not toward Her2/neu low expressing MDA-231 human breast cancer cells. Similarly generated CTLs stimulated with irrelevant peptide pulsed dendritic cells did not show significant cytotoxicity towards breast cancer targets. The phenotypes of cells in culture showed high percentage of CD3+, CD4+ and CD8+T cells as determined by flow cytometry. However, the antibody mediated blocking assay demonstrated that only HLA-Class I restricted CD8+ cells are involved in the cytotoxicity. Furthermore, in vivo studies showed that treatment of SCID mice bearing MDA-453 tumor with Her2/neu-specific CTLs resulted in significant inhibition of tumor growth compared to untreated tumor bearing control mice. These results demonstrate that human umbilical cord blood mononuclear cells are a good source for generating Her2/neu-specific CTLs against human breast cancer both in vitro and in vivo.

AB - The Her2/neu oncogene encodes a transmembrane protein with homology to the epidermal growth factor receptor. Overexpression of this gene contributes to the aggressiveness of breast cancer and poor prognosis. Therefore, Her2/neu is an ideal target molecule for generating effective cytotoxic T lymphocytes (CTLs) against breast cancers. This study reports on the generation of Her2/neu-specific CTL from umbilical cord blood mononuclear cells (UCBC) using dendritic cells primed with Her2/neu-derived peptide (KIFGSLAFL, E75) for immunostimulation. The CTLs showed specific cytotoxicity to Her2/neu high expressing MDA-453 but not toward Her2/neu low expressing MDA-231 human breast cancer cells. Similarly generated CTLs stimulated with irrelevant peptide pulsed dendritic cells did not show significant cytotoxicity towards breast cancer targets. The phenotypes of cells in culture showed high percentage of CD3+, CD4+ and CD8+T cells as determined by flow cytometry. However, the antibody mediated blocking assay demonstrated that only HLA-Class I restricted CD8+ cells are involved in the cytotoxicity. Furthermore, in vivo studies showed that treatment of SCID mice bearing MDA-453 tumor with Her2/neu-specific CTLs resulted in significant inhibition of tumor growth compared to untreated tumor bearing control mice. These results demonstrate that human umbilical cord blood mononuclear cells are a good source for generating Her2/neu-specific CTLs against human breast cancer both in vitro and in vivo.

KW - Breast cancer

KW - Cord blood

KW - Cytotoxic T lymphocytes (CTLs)

KW - Dendritic cells (DCs)

KW - Her2/neu

UR - http://www.scopus.com/inward/record.url?scp=0942301254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0942301254&partnerID=8YFLogxK

U2 - 10.1023/B:BREA.0000010688.55353.a8

DO - 10.1023/B:BREA.0000010688.55353.a8

M3 - Article

VL - 83

SP - 15

EP - 23

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -